TROG 07.04

Title

Chemoradiation Treatment for Head and Neck Cancer

Summary

The purpose of this study is to assess the safety and feasibility of combining radiotherapy and carboplatin (a chemotherapy drug) with a new drug called cetuximab in patients with locally advanced head and neck cancer

Final accrual

Trial Status

Closed to follow-up, December 2014

Trial chairpersons

Assoc Prof June Corry, Peter MacCallum Cancer Centre, VIC
Prof Danny Rischin, Peter MacCallum Cancer Centre, VIC

Trial contact

Chris Griffiths
Phone: 03 9656 5829
Email: Christopher.Griffiths@petermac.org

Further information

TROG 07.04 on Australian Cancer Trials website

Trial resources for TROG members

TROG 07.04 member page

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.

Tweets by @TROGfightcancer